BIS has launched the 2012 Annual Innovation Report, providing a snapshot of innovation performance in the UK covering the period up to 2010. Metrics analysed include investment and R&D, venture capital, skills and the economic impact of innovation.
During 2011/12 NUH maintained excellence in research in a changing and challenging environment. Key achievements during this period include 8,874 patients recruited in 293 NIHR adopted studies, 1644 patients recruited to 157 commercial studies, 14 new NIHR research grants awarded, £8.7M external funding attracted by three BRUs, More than 4,000 biosamples and £420K of external funding for the Nottingham Health Science Biobank. Continue reading
NUH fully complies with the NIHR RSS framework. The NIHR RSS is a national framework for local NHS research management. This framework enables front line staff to collaborate in offering a consistent professional streamlined service, with proportionate procedures, to … Continue reading
The NIHR i4i programme is launching a new funding stream – the i4i Challenge Awards programme – that aims to support researchers to demonstrate the healthcare benefits of their prototype medical devices in a clinical setting. The NIHR has allocated £15 million over the next three years to this new programme. A typical i4i Challenge Award project will prototype a medical device that has been developed to aid the identification, diagnosis or monitoring of a single disease in everyday clinical practice. Continue reading
Three key initiatives designed to support the UK’s Life Sciences industry have been announced by Government including a new £180 million ‘valley of death’ catalyst fund for new medical breakthroughs. This fund will target the funding gap that exists – the so called ‘valley of death’ – between the moment that a bright new idea is developed in the laboratory and the point when a new drug or technology can be invested in by the market. Continue reading
This year’s annual report provides a summary of research activity at NUH during 2010/11, and describes progress against the NUH R&D Strategy. During this period NUH increased recruitment to NIHR portfolio clinical trials by 46%, ranking amongst the top six NHS Trusts in the country and increased research income from the NIHR and NIHR partners by 50%. Continue reading
The NIHR’s annual report for 2010/11 has just been published and features the Nottingham Biomedical Research Unit in Hearing and its work with the University of Nottingham to produce a revolutionary controlled-release antibiotic pellet. Continue reading
The Softened Water Eczema Trial won the prize for Best Paper at the 91st Annual Meeting for the British Association of Dermatologists this year.
Funded by the NIHR Health Technology Assessment programme, Nottingham was one of eight recruiting centres for the … Continue reading
2009/10 has been a year of major success for NUH, with an 85% increase in recruitment to portfolio clinical trials and a circa 100% increase in NIHR funding. NUH R&D has continued to develop a strategic function which underpins the … Continue reading